This Solicitation opportunity from Department Of Defense was posted on May 28, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
LIDOCAINE HYDROCHLO
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
This contract covers the procurement of Lidocaine Hydrochloride and Epinephrine Injection, USP, specifically a 2% Lidocaine Hydrochloride solution combined with a 1:100,000 ratio of Epinephrine, supplied in 1.7 ml cartridges packaged in units of 50. The product is intended for local dental anesthesia via nerve block or infiltration only, is latex-free, must be stored at controlled room temperature below 25°C, protected from light and freezing, and has a total shelf life of 15 months with a minimum of 13 months remaining upon receipt. Packaging requirements mandate that each unit be sealed in containers that prevent damage and breakage, packed in commercial exterior shipping containers, and marked according to Medical Marking Standard No. 1. The contract also specifies adherence to various Department of Defense packaging and quality standards, with particular reference to commercial packaging protocols and applicable technical and quality requirements listed in the DLA Master List. The procurement involves delivery within 20 days FOB destination to a specified military vessel (USS Bainbridge DDG 96) via fast and traceable shipping methods, explicitly excluding parcel post. The contract quantity is one packaged unit of 50 cartridges, controlled under NSN 6505-01-597-1328. Inspection and acceptance occur at the destination, and government removal of identification applies for non-accepted supplies. The contract emphasizes compliance with FDA regulation and requires referral to product specialists during acquisition. Vendor information includes several recognized dental supply companies, and overall contract administration is managed by the Department of Defense’s Medical Supply Chain Pharmacy FSA with detailed contact and logistical instructions provided.
General Info
Agency
NAICS
Place of Performance
UNIT 100325 BOX1, FPO, AE, 09565, USSet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION, USP
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
.
2 PCT LIDOCAINE HYDROCHLORIDE AND RATIO OF 1:100,000 EPINEPHRINE<(>,<)>
.
1.7 ML CARTRIDGE, 50'S
.
U/I: PG (50 CARTRIDGES)
.
.
STORE AT USP CONTROLLED ROOM TEMPERATURE, BELOW 25°C (77°F).
SPE2DP-26-T-3581
SECTION B
PROTECT FROM LIGHT. DO NOT PERMIT TO FREEZE. LATEX-FREE
.
FOR LOCAL DENTAL ANESTHESIA BY NERVE BLOCK
OR INFILTRATION ONLY.
.
TOTAL SHELF LIFE IS 15 MONTHS.
.
THERE SHALL BE A MINIMUM OF 13 MONTHS
OF REMAINING SHELF LIFE AT THE TIME OF
RECEIPT BY THE FIRST GOVERNMENT ACTIVITY.
.
.
LABELING AND MARKING MUST IN ACCORDANCE WITH
MEDICAL MARKING STANDARD
1 PG = 50 EA
.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS012: Shelf-life requirement RS001 for a TYPE I (CODE J) item with a shelf life of 15 months (non-extendable) applies to this item.
HENRY SCHEIN, INC. 0NUS8 P/N 02A0100 HENRY SCHEIN, INC. 0NUS8 P/N 2285791 HENRY SCHEIN, INC. 0NUS8 P/N 4651205 HENRY SCHEIN, INC. 0NUS8 P/N NDC00404-6512-05 DARBY DENTAL SUPPLY, LLC 5GKH5 P/N 9515491 BENCO DENTAL SUPPLY CO. 1V865 P/N NDC66975-0425-51
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016947057 0001 PG 1.000
NSN/MATERIAL:6505015971328
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
SPE2DP-26-T-3581
SECTION B
PR: 7016947057 PRLI: 0001 CONT’D
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
V23153
USS BAINBRIDGE DDG 96
UNIT 100325 BOX1
FPO AE 09565
US
VESSEL SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
V23153
USS BAINBRIDGE DDG 96
DLA VENDORS: USE VSM FOR
US
RDD 777 SHIPMENT. SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
M/F: (TCN) V231536144HM23
RDD: 777
PROJ: EK5 TP 2
SUPP ADD: YNHM01 SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 05
DIC: A4A DIST: 9B ADV: 2A FC: S7
Need Ship Date:00/00/0000 Original Required Delivery Date:06/01/2026
SPE2DP-26-T-3581 NSN/Part Number: 6505-01-597-1328 Quantity: 1 PG Purchase Request: 7016947057QTY: 1 Delivery: 20 days ADO
